Premier Research Group appoints new chief executive
This article was originally published in SRA
Executive Summary
UK-based pharmaceutical and medical device contract research organisation Premier Research Group has appointed Ludo Reynders as its new chief executive. Dr Reynders was previously chief executive of AAIPharma, overseeing that firm's transition from a specialty pharmaceutical company to a full-service drug development services company. Dr Reynders worked at Quintiles prior to joining AAIPharma, holding positions such as managing director of PharmaBio evelopment and chief executive of Quintiles Development Services.